Similar articles

• Use of interferon-gamma release assay for latent tuberculosis infection screening in older adults exposed to tuberculosis in a nursing home.

  Katsenos S, Nikolopoulou M, Gartzonika C, Manda-Stachouli C, Gogali A, Grypaiou C, Mavridis A, Constantopoulos SH, Daskalopoulos G. Katsenos S, et al. J Am Geriatr Soc. 2011 May;59(5):858-62. doi: 10.1111/j.1532-5415.2011.03367.x. Epub 2011 Apr 21. J Am Geriatr Soc. 2011. PMID: 21517785
• Deployment-related testing and treatment for latent tuberculosis infection, part II.

  Mancuso JD, Keep LW. Mancuso JD, et al. Mil Med. 2011 Oct;176(10):1088-92. doi: 10.7205/milmed-d-11-00141. Mil Med. 2011. PMID: 22128639 Review.
• Screening for Latent Tuberculosis Infection: A Key Step Toward Achieving Tuberculosis Elimination in the United States.

  Reves R, Daley CL. Reves R, et al. JAMA Intern Med. 2016 Oct 1;176(10):1439-1440. doi: 10.1001/jamainternmed.2016.5464. JAMA Intern Med. 2016. PMID: 27599130 No abstract available.
• Comparison of a commercial interferon-gamma release assay and tuberculin skin test for the detection of latent tuberculosis infection in Hong Kong arthritis patients who are candidates for biologic agents.

  So H, Yuen CS, Yip RM. So H, et al. Hong Kong Med J. 2017 Jun;23(3):246-50. doi: 10.12809/hkmj164880. Epub 2017 Jan 27. Hong Kong Med J. 2017. PMID: 28126971
• Can ELISpot replace the tuberculin skin test for latent tuberculosis?

  Greveson K. Greveson K. Br J Nurs. 2009 Nov 12-25;18(20):1248-54. doi: 10.12968/bjon.2009.18.20.45120. Br J Nurs. 2009. PMID: 20081663 Review.